Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001104659-15-076190)

Filing Details

Accession Number:
0001104659-15-076190
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-11-05 14:37:46
Reporting Period:
2015-11-03
Filing Date:
2015-11-05
Accepted Time:
2015-11-05 14:37:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1552451 Myokardia Inc MYOK Pharmaceutical Preparations (2834) 455500552
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1121404 Sanofi 54 Rue La Boetie
Paris I0 75008		 No No Yes No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Par Value Per Share $ 0.0001 Acquisiton 2015-11-03 2,318,899 $0.00 2,318,899 No 4 C Indirect Via wholly owned subsidiary Aventis Inc.
Common Stock Par Value Per Share $ 0.0001 Acquisiton 2015-11-03 900,000 $10.00 3,218,899 No 4 P Indirect Via wholly owned subsidiary Aventis Inc.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect Via wholly owned subsidiary Aventis Inc.
No 4 P Indirect Via wholly owned subsidiary Aventis Inc.
Reported Derivative Transactions
Show Other Fields >>
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stocks Series A-1 redeemable convertible preferred stock Disposition 2015-11-03 6,666,667 $0.00 1,814,059 $0.00
Common Stocks Series B redeemable convertible preferred stock Disposition 2015-11-03 1,855,288 $0.00 504,840 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. Conversion upon Initial Public Offering